Drug Discovery Today

SEPTEMBER 9, 2022

On the 26th-27th of October, Vilnius is hosting the European Forum for Industrial Biotechnology & the Bioeconomy 2022 (EFIB'22). The forum will bring together business leaders, entrepreneurs, scientists, and investors as one of Europe's most meaningful events for biotechnology. We caught up with the Executive Director of the Lithuanian Biotechnology Association, Agne Vaitkeviciene, who told us about the importance of the forum and the potential of the Lithuanian life sciences sector.

Science 113

Science 113

Antidote

SEPTEMBER 30, 2022

Since 1999, October has been recognized as Health Literacy Month. The goal, as defined by the Institute for Healthcare Advancement , is to raise awareness about the importance of understandable health information — but what is health literacy and why is it important?

98

98

Drug Patent Watch

SEPTEMBER 15, 2022

This chart shows the pharmaceutical companies with the most patents in Ireland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Ireland? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 92

Pharmaceutical Companies Pharmaceuticals Drugs 92

Drug Channels

SEPTEMBER 7, 2022

As regular readers know, the biosimilar boom for provider-administered drugs has been accelerating. Prices are dropping while adoption accelerates. In many therapeutic areas, biosimilars’ market share is approaching 80%. In the video below, I review these developments and discuss lessons from the launch of Semglee, the first interchangeable insulin.

Biosimilars 87

Biosimilars Marketing Drugs Production 87

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Treatment

Eye on FDA

SEPTEMBER 28, 2022

FDA published notice recently that the Office of Prescription Drug Promotion (OPDP) was proposing some new research related to the promotion of medicines by pharmaceutical companies. The research was new (kind of) but the direction was more of the same old focus – direct-to-consumer advertising (DTC). First, just a note on why the research is of importance at all.

Research 69

Research Pharmaceutical Companies FDA Production 69

Advarra

SEPTEMBER 30, 2022

Is the clinical research industry winning or failing at innovation? It probably depends on who you ask and likely full of nuance. In the past decade, trials have evolved to include not just traditional drugs and medical devices, but also innovations like cell and gene therapies, wearables, and more. As exciting as that growth may be, it invites more complexity.

Research 52

Research Clinical Research Trials FDA Approval 52

Antidote

SEPTEMBER 12, 2022

There are many factors one should consider before deciding to enroll in a clinical trial. Though every clinical trial is designed to help researchers advance their knowledge about a specific condition, the details regarding a study’s duration, risks, benefits, and required time commitment can vary. When determining how to participate in clinical trials, these elements are all good things to discuss with the research team to determine if a study is a good fit.

Clinical Trials 97

Clinical Trials Trials Research 97

Drug Patent Watch

SEPTEMBER 27, 2022

This chart shows the drugs with the most patents in Ukraine. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Ukraine? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceuticals 86

Pharmaceuticals Drugs 86

Drug Channels

SEPTEMBER 16, 2022

Today’s guest post comes from Edward Hensley, Chief Commercial Officer at AssistRx. Edward compares the pros and cons of electronic benefit verification using artificial intelligence, direct connectivity, or data connectivity. He also describes the circumstances where each solution provides the greatest value. To learn more, download AssistRx’s free eBook: Specialty Drug Patient Support Programs: 2022 Progress Report.

Drugs 85

Drugs 85

NIH Director's Blog: Drug Development

SEPTEMBER 27, 2022

Wearable electronic sensors hold tremendous promise for improving human health and wellness. That promise already runs the gamut from real-time monitoring of blood pressure and abnormal heart rhythms to measuring alcohol consumption and even administering vaccines. Now a new study published in the journal Science Advances [1] demonstrates the promise of wearables also extends to the laboratory.

Drug Development 52

Drug Development Drugs Engineering Therapies 52

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Advarra

SEPTEMBER 29, 2022

Informed consent is one of the central protections the regulations provide to research subjects. This tip sheet outlines the regulatory requirements for research informed consent forms (ICFs). The regulatory requirements for informed consent will vary depending upon which regulations apply to the conduct of a particular study. Note: Individual institutional review boards (IRBs) may have their own specific policies regarding how ICFs should be formatted, how to address certain regulatory criteri

Regulations 52

Regulations FDA Research Treatment 52

Drug Discovery Today

SEPTEMBER 8, 2022

Salipro Biotech strengthens its IP portfolio protecting its innovative, proprietary technology to enable the development of therapeutics against challenging drug targets, including GPCR’s, SLCs and Ion Channels.

Drugs 100

Drugs 100

Antidote

SEPTEMBER 5, 2022

Because Hunter syndrome is a rare, inherited disorder that mostly impacts children, it can lead to many questions from the parents and caregivers of those that are affected.

98

98

Drug Patent Watch

SEPTEMBER 24, 2022

Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Inc and is included in two NDAs. It is available from one supplier. There are forty patents…. The post New patent for Pharmacyclics Inc drug IMBRUVICA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 82

Drugs Marketing 82

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Clinical Trials

Drug Channels

SEPTEMBER 9, 2022

Today’s guest post comes from Kristina Crockett, Vice President of Product Management at CoverMyMeds. Kristina discusses the affordability challenges that patients face in our complex and confusing healthcare system. She then explains how data and technology can help payers, manufacturers, and providers improve medication access. To learn more about CoverMyMeds’ comprehensive affordability solutions, download Overcoming Medication Affordability Challenges with Patient-Centered Solutions.

Production 78

Production Drugs 78

National Institute on Drug Abuse: Nora's Blog

SEPTEMBER 27, 2022

Supporting Needed Research on Recovery mfleming Tue, 09/27/2022 - 13:33 Nora's Blog September 28, 2022 National Recovery Month (Recovery Month), which started in 1989, is a national observance held every September to promote and support new evidence-based treatment and recovery practices, the nation’s strong and proud recovery community, and the dedication of service providers and communities who make recovery in all its forms possible.

Research 52

Research Treatment Science Trials 52

Advarra

SEPTEMBER 23, 2022

The Food and Drug Administration (FDA) is the federal entity in the U.S. charged with (among other things) “ensur[ing] that safe and effective drugs are available to improve the health of the people in the United States.” . Before the FDA permits a pharmaceutical drug product to be lawfully marketed, sponsors are required to submit information about the product’s safety and efficacy so the FDA can determine : .

Clinical Trials 52

Clinical Trials Trials FDA Regulations 52

Drug Discovery Today

SEPTEMBER 16, 2022

Why opening up communication channels can stop the spread of misinformation

Laboratories 113

Laboratories 113

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Clinical Trials

Antidote

SEPTEMBER 21, 2022

September 21 is World Alzheimer’s Day , a day of recognition aimed at increasing awareness of and understanding the issues faced by people living with Alzheimer’s. Though there are many conditions that can cause memory loss , Alzheimer’s is one of the most common — it is estimated that 5.4 million Americans are living with the condition , most of whom are over the age of 65.

97

97

Drug Patent Watch

SEPTEMBER 22, 2022

This chart shows the patent expirations for film dosed drugs over the next decade. The term of drug patents varies. The basic term for a patent is 20 years from…. The post Film dosed drug patent expirations by year appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 79

Drugs 79

Drug Channels

SEPTEMBER 20, 2022

On October 11, 2022, Drug Channels Institute will release The 2022–23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. This report—our thirteenth edition— remains the most comprehensive, fact-based tool for understanding and analyzing the large and growing U.S. pharmaceutical distribution industry. We are providing you with the opportunity to preorder this thoroughly updated and revised 2022-23 edition at special discounted prices.

Pharmaceuticals 75

Pharmaceuticals Drugs 75

Crown Bioscience

SEPTEMBER 22, 2022

Modern high-content imaging (HCI) and analysis platforms provide simultaneous multi-parameter visualization and quantification of thousands of cells including 3D in vitro models. This highly comprehensive information provides deep insights into the mechanisms of action, toxicity, and synergistic and off-target effects of single and combinations of compounds.

Drugs 52

Drugs 52

Olympian Clinical Research

SEPTEMBER 22, 2022

It is estimated that about 14% of the population will experience onychomycosis, more commonly known as toenail fungus, at some point in their lives. Toenail fungus may affect people of all ages, but it is more common in adults over 60. Furthermore, it can quickly spread to other toenails if left untreated. This all-inclusive guide will teach you everything you need to know about toenail fungus, from identifying the symptoms to exploring treatment options.

Clinical Research 52

Clinical Research Clinical Trials Treatment Doctors 52

ProRelix Research

SEPTEMBER 21, 2022

According to the World Health Organization (WHO), cancer is the leading cause of death worldwide, with a death rate of one in six in 2020 (1). Aside from the high […]. The post Cancer Clinical Trials: USA Scenario and Study Designs appeared first on ProRelix Research.

Clinical Trials 52

Clinical Trials Trials Research 52

Antidote

SEPTEMBER 7, 2022

Strong clinical trial recruitment strategies start from a place of patient centricity, incorporating a variety of outreach methods designed to educate and engage potential participants. Creating a structured clinical trial patient recruitment plan before outreach begins is a smart way to ensure that the process is organized, efficient, and keeps the patient experience as the top priority.

Clinical Trials 92

Clinical Trials Trials 92

Drug Patent Watch

SEPTEMBER 7, 2022

This is a guest post by Oleksandr Topachevskyi at Digital Health Outcomes. Oleksandr may be contacted at sales@digitalho.com Commercial, nonprofit, and government companies are quite good at calculating the costs…. The post Social Return on Investment appeared first on DrugPatentWatch - Make Better Decisions.

Government 82

Government 82

Drug Channels

SEPTEMBER 23, 2022

Today’s guest post comes from Lindsey Alves, Vice President of Customer Success at Kalderos. Lindsey describes the challenges facing remote workers who manage government-managed drug discount programs. As she explains, all drug discount stakeholders require novel technology-enabled collaboration tools. To learn more, register for Kalderos’ panel discussion, The Dreaded Duplicate Discounts: Collaborating in the New Hybrid Working Landscape.

Drugs 74

Drugs Government 74

Translation

SEPTEMBER 19, 2022

Like most startups, Halo looks much different today than it did when we started, but the problem we’re solving hasn’t changed — there are thousands of scientific discoveries that never materialize into real-world solutions. At first, we tried to solve this problem by crowdfunding research projects to help leapfrog these nascent technologies over the so-called “valley of death.

Science 52

Science Licensing Licensing Government 52

sptlabtech

SEPTEMBER 20, 2022

Researchers need biobanks to provide high-quality samples via optimal processing, secure storage, and preservation under the appropriate conditions for the lifetime of the sample. Fundamental to the success of a biobank is the ability to preserve high-quality samples for many decades. Automated storage solutions offer both quantitative and more intangible benefits to the biobank workflow, such as integrated sample traceability, secure storage, increased retrieval speed, and sample preservation.

Research 52

Research 52

Advarra

SEPTEMBER 20, 2022

Site selection for clinical trials is often one of the biggest headaches for pharmaceutical sponsors and contract research organizations (CROs). Even with enough due diligence, activated sites can still fail to recruit the desired number of study participants. Reliable industry estimates peg the cost of these under-accruing sites to the pharmaceutical industry at between $600,000 to eight million dollars per day of trial delay.

Clinical Trials 52

Clinical Trials Trials Research Pharmaceuticals 52

Antidote

SEPTEMBER 29, 2022

Though it has only been identified since the early 1990s, Eosinophilic Esophagitis (EoE) has come to be known as a major cause of gastrointestinal illness. Though there are still a lot of unknowns surrounding EoE, ongoing research hopes to provide patients and medical professionals with more insights in the future.

Research 52

Research 52

Drug Patent Watch

SEPTEMBER 21, 2022

This chart shows the drugs with the most patents in Sweden. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Sweden? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceuticals 76

Pharmaceuticals Drugs 76

Drug Channels

SEPTEMBER 13, 2022

By now, you have already read innumerable articles explaining what’s in the new Inflation Reduction Act of 2022 (IRA; P.L. 117-169). Today, I want to highlight three significant—and presumably unintended—drug channel consequences from the hastily-passed IRA legislation. These include disruption to the now-booming biosimilar market, the prospects of physician/hospital vertical integration that will raise commercial healthcare costs and expand 340B, and the need for complex new processes to admini

Biosimilars 74

Biosimilars Pharmacy Hospitals Marketing 74